RhumbLine Advisers’s Harvard Bioscience HBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $23.4K | Buy |
|
|||||
|
2024
Q4 | $83.2K | Buy |
|
|||||
|
2024
Q3 | $104K | Sell |
|
|||||
|
2024
Q2 | $136K | Buy |
|
|||||
|
2024
Q1 | $162K | Buy |
|
|||||
|
2023
Q4 | $196K | Sell |
|
|||||
|
2023
Q3 | $158K | Buy |
|
|||||
|
2023
Q2 | $190K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $225K | Buy |
|
|||||
|
2021
Q4 | $174K | Sell |
|
|||||
|
2021
Q3 | $177K | Buy |
|
|||||
|
2021
Q2 | $196K | Sell |
|
|||||
|
2021
Q1 | $235K | Sell |
|
|||||
|
2020
Q4 | $190K | Buy |
|
|||||
|
2020
Q3 | $109K | Sell |
|
|||||
|
2020
Q2 | $137K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $210K | Sell |
|
|||||
|
2018
Q4 | $156K | Buy |
|
|||||
|
2018
Q3 | $174K | Buy |
|
|||||
|
2018
Q2 | $164K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $127K | Buy |
|
|||||
|
2015
Q4 | $130K | Buy |
|
|||||
|
2015
Q3 | $134K | Buy |
|
|||||
|
2015
Q2 | $188K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $152K | Sell |
|
|||||
|
2013
Q4 | $157K | Sell |
|
|||||
|
2013
Q3 | $187K | Buy |
|
|||||
|
2013
Q2 | $168K | Buy |
|